drugset / Trial / NCT04721223
JAB-3068 Activity in Adult Patients With Advanced Solid Tumors
Non-randomizedSequentialOpen-labelTreatment
Summary
To evaluate the safety and tolerability of JAB-3068 administered in investigational regimens in adult participants with advanced solid tumors.
Timeline
- Start
- 2021-04-26
- Primary completion
- 2023-12-29
- Completion
- 2023-12-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | JAB-3068 | Small molecule | — | Oral |
| Subject | Toripalimab | Monoclonal antibody | — | Intravenous |